Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Demarchi

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Preventive Cardiology|December 17, 2019
Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionAlberto Somaschini, Stefano Cornara, Andrea Demarchi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2020
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes?Andrea Demarchi, Stefano Cornara, Alberto Somaschini, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 6, 2019
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and plateletsAlberto Somaschini, Andrea Demarchi, Stefano Cornara, et al.
Annals of Neurology|September 24, 2005
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathyLaura Obici, Andrea Demarchi, Giulia de Rosa, et al.
Oncotarget|May 17, 2018
IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapyGiacomo Quattrocchio, Antonella Barreca, Andrea Demarchi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 25, 2020
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarctionAlessandro Mandurino-Mirizzi, Andrea Demarchi, Marta Ruffinazzi, et al.
Circulation. Cardiovascular Interventions|May 31, 2019
Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary InterventionMarco Ferlini, Roberta Rossini, Giuseppe Musumeci, et al.
Journal of the American Heart Association|February 1, 2021
Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator ReplacementAndrea Demarchi, Stefano Cornara, Antonio Sanzo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 27, 2021
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionAlessandro Mandurino-Mirizzi, Vilma Kajana, Stefano Cornara, et al.
International Journal of Cardiology|September 19, 2021
Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groupsNicola Cosentino, Marta L Resta, Alberto Somaschini, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Preventive Cardiology|December 17, 2019
Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionAlberto Somaschini, Stefano Cornara, Andrea Demarchi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2020
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes?Andrea Demarchi, Stefano Cornara, Alberto Somaschini, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 6, 2019
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and plateletsAlberto Somaschini, Andrea Demarchi, Stefano Cornara, et al.
Annals of Neurology|September 24, 2005
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathyLaura Obici, Andrea Demarchi, Giulia de Rosa, et al.
Oncotarget|May 17, 2018
IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapyGiacomo Quattrocchio, Antonella Barreca, Andrea Demarchi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 25, 2020
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarctionAlessandro Mandurino-Mirizzi, Andrea Demarchi, Marta Ruffinazzi, et al.
Circulation. Cardiovascular Interventions|May 31, 2019
Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary InterventionMarco Ferlini, Roberta Rossini, Giuseppe Musumeci, et al.
Journal of the American Heart Association|February 1, 2021
Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator ReplacementAndrea Demarchi, Stefano Cornara, Antonio Sanzo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 27, 2021
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionAlessandro Mandurino-Mirizzi, Vilma Kajana, Stefano Cornara, et al.
International Journal of Cardiology|September 19, 2021
Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groupsNicola Cosentino, Marta L Resta, Alberto Somaschini, et al.
Pageof 6